Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor

Adam Graham Grieve1, Hongmei Xu1, Ulrike Künzel1

  • 1Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.

Elife
|April 23, 2017
PubMed

Insights

iRhom2 regulates tumor necrosis factor-alpha-converting enzyme (TACE) activity by binding to it throughout its lifecycle. This interaction, modulated by phosphorylation, licenses TACE

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Proteolytic cleavage of cell surface ligands regulates intercellular signaling.
  • TACE (TNFα-converting enzyme) sheds inflammatory cytokines like TNFα and EGF receptor ligands.
  • iRhoms control TACE transport and maturation but their precise role in TACE activation is unclear.

Purpose of the Study:

  • To elucidate the role of iRhom2 in the regulation of TACE activity and shedding.
  • To investigate the molecular mechanism by which iRhom2 controls TACE function at the cell surface.
  • To determine the physiological relevance of the iRhom2-TACE interaction in inflammatory responses.

Main Methods:

  • Co-immunoprecipitation to assess iRhom2-TACE association throughout the secretory pathway.
  • Analysis of TACE shedding and activity in cells expressing wild-type and mutant iRhom2.
  • Phosphorylation site mapping and 14-3-3 binding assays.
  • In vivo studies using primary mouse macrophages to assess inflammatory responses.

Main Results:

  • iRhom2 remains associated with TACE from the ER to the cell surface, stabilizing mature TACE.
  • ERK1/2-mediated phosphorylation of iRhom2's N-terminus and subsequent 14-3-3 binding license TACE proteolytic activity at the plasma membrane.
  • This iRhom2-dependent TACE activation mechanism triggers inflammatory responses in macrophages.

Conclusions:

  • iRhom2 acts as a crucial regulator of TACE by binding to it throughout its lifecycle.
  • Post-translational modifications of iRhom2, including phosphorylation, are critical for licensing TACE shedding activity.
  • The iRhom2-TACE axis represents a key pathway controlling stimulated cytokine and growth factor signaling, impacting inflammatory processes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.3K